Dear Doctor Letter (Rote-Hand-Brief) on Thalidomide Celgene™ (thalidomide): Occurrence of thromboembolic events
2011.04.21
Active substance: thalidomide
Important information on the occurrence of thromboembolic events associated with Thalidomide Celgene™ (thalidomide).
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN